EUSA Pharma, Jazz Pharmaceuticals deal

Essex Bidco Ltd. acquired five approved specialty hospital products and related commercial infrastructure from Jazz for about $33 million in cash. Jazz gained rights to the products under its 2012 acquisition of EUSA Pharma Inc. Essex Bidco then re-established itself as a newco under the name EUSA Pharma. The CEO of the newco is Bryan Morton, who was founder and CEO of the original EUSA. The company plans to expand its portfolio through acquisitions and in-licensing. ...